Real-world evidence (RWE) on the clinical outcomes in 1st-line chemotherapy (CT) for fit and vulnerable patients (pts) with metastatic colorectal cancer (mCRC)

被引：0

作者：

Yamazaki, K. ^{[1
]}

Yamanaka, T. ^{[2
]}

Hamano, T. ^{[3
]}

机构：

[1] Shizuoka Canc Ctr, Dept Gastrointestinal Oncol, Shizuoka, Japan

[2] Yokohama City Univ Med, Biostat Dept, Yokohama, Kanagawa, Japan

[3] P4 Stat Co Ltd, Head Off, Tokyo, Japan

来源：

关键词：

D O I：

10.1016/j.annonc.2020.08.556

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

445P

引用

页码：S431 / S431

页数：1